Please turn JavaScript on
header-image

Rarediseaseadvisornewsfeed

Subscribe in seconds and receive Rarediseaseadvisornewsfeed's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.

You can select the updates using tags or topics and you can add as many websites to your feed as you like.

And the service is entirely free!

Follow Rarediseaseadvisornewsfeed: Attention Required! | Cloudflare

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  11.54 / day

Message History

Systemic autoimmune rheumatic disease–associated interstitial lung disease (SARD-ILD) is associated with better survival than IPF, according to a new study.

The post Study Supports Diagnosis-Based Management in ILD appeare...


Read full story

Patients with myasthenia gravis (MG) show elevated docosahexaenoic acid (DHA) levels, and supplementation may worsen severity.

The post DHA Supplementation May Exacerbate Myasthenia Gravis by ...


Read full story

In a recent study, TMLI conditioning in MDS achieved 100% overall and leukemia-free survival with no relapses at median 192 days.

The post TMLI Targeted Conditioning Delivers High Efficacy in MDS and ALL appeared ...


Read full story

A potential new biomarker, 4,5-DHHA, shows consistent elevation across several mitochondrial diseases, including TK2d.

The post Newly Identified Biomarker Tracks Mitochondrial Dysfunction in ...


Read full story

Inhalable nanoparticles simultaneously delivering saracatinib and nintedanib to the lungs can offer promise in the treatment of IPF, research shows.

The post New Inhalable Nanoparticles Offer Promise in IPF, Other ...


Read full story